An experienced physiotherapist prescribing and administering corticosteroid and local anaesthetic injections to the shoulder in an Australian orthopaedic service, a non-inferiority randomised controlled trial and economic analysis: study protocol for a r
详细信息 查看全文
- 作者：Darryn Marks ; Leanne Bisset ; Michael Thomas ; Shaun O’Leary ; Tracy Comans…
- 关键词：Extended scope practice ; Physiotherapy ; Physical therapy ; Orthopaedic ; Shoulder ; Corticosteroid injection ; Economic
- 刊名：Trials
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：15
- 期：1
- 全文大小：634 KB
- 参考文献：Australian Hospital Statistics 2011-2. AIHW, Canberra, Australia
1. Hospital Performance http://www.health.qld.gov.au/performance/default.asp
Data current as at 1 November 2013. Orthopaedics Outpatient Waiting List. Queensland Health, Brisbane, Australia
Caring for Older Australians, Report No. 53, Final Inquiry Report. Australian Government, Canberra
2. Iorio, R, Robb, WJ, Healy, WL, Berry, DJ, Hozack, WJ, Kyle, RF, Lewallen, DG, Trousdale, RT, Jiranek, WA, Stamos, VP, Parsley, BS (2008) Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am 90A: pp. 1598-1605 CrossRef
3. Duckett, SJ (2005) Health workforce design for the 21st century. Aust Health Rev 29: pp. 201-210 CrossRef
4. Desmeules, F, Toliopoulos, P, Roy, J-S, Woodhouse, LJ, Lacelle, M, Leroux, M, Girard, S, Feldman, DE, Fernandes, JC (2013) Validation of an advanced practice physiotherapy model of care in an orthopaedic outpatient clinic. BMC Musculoskelet Disord 14: pp. 162-162 CrossRef
5. Razmjou, H, Robarts, S, Kennedy, D, McKnight, C, MacLeod, AM, Holtby, R (2013) Evaluation of an advanced-practice physical therapist in a specialty shoulder clinic: diagnostic agreement and effect on wait times. Physiother Can 65: pp. 46-55 CrossRef
6. Stanhope, J, Grimmer-Somers, K, Milanese, S, Kumar, S, Morris, J (2012) Extended scope physiotherapy roles for orthopedic outpatients: an update systematic review of the literature. J Multidiscip Healthc 5: pp. 37-45
Allied Health Professions Prescribing and Medicines Supply Mechanisms Scoping Project Report. Department of Health, London
7. McBeth, J, Jones, K (2007) Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 21: pp. 403-425 CrossRef
8. Linsell, L, Dawson, J, Zondervan, K, Rose, P, Randall, T, Fitzpatrick, R, Carr, A (2006) Prevalence and incidence of adults consulting for shoulder conditions in UK primary care; patterns of diagnosis and referral. Rheumatology (Oxford) 45: pp. 215-221 CrossRef
9. Lewis, JS, Green, AS, Dekel, S (2001) The aetiology of subacromial impingement syndrome. Physiotherapy 87: pp. 458-469 CrossRef
10. Buchbinder, R, Green, S, Youd, JM (2003) Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev 1: pp. CD004016
11. Blair, B, Rokito, AS, Cuomo, F, Jarolem, K, Zuckerman, JD (1996) Efficacy of injections of corticosteroids for subacromial impingement syndrome. J Bone Joint Surg Am 78: pp. 1685-1689
12. Green, S, Buchbinder, R, Hetrick, S (2003) Physiotherapy interventions for shoulder pain. Cochrane Database Syst Rev 2: pp. CD004258
13. James, M, Stokes, EA, Thomas, E, Dziedzic, K, Hay, EM (2005) A cost consequences analysis of local corticosteroid injection and physiotherapy for the treatment of new episodes of unilateral shoulder pain in primary care. Rheumatology (Oxford) 44: pp. 1447-1451 CrossRef
14. Jowett, S, Crawshaw, DP, Helliwell, PS, Hensor, EMA, Hay, EM, Conaghan, PG (2013) Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: a trial-based analysis. Rheumatology (Oxford) 52: pp. 1485-1491 CrossRef
15. Bloom, JE, Rischin, A, Johnston, RV, Buchbinder, R (2012) Image-guided versus blind glucocorticoid injection for shoulder pain. Cochrane Database Syst Rev 8: pp. CD009147
16. Buchbinder, R, Staples, MP, Shanahan, EM, Roos, JF (2013) General practitioner management of shoulder pain in comparison with rheumatologist expectation of care and best evidence: an Australian national survey. Plos One 8: pp. e61243-e61243
文摘
Background The early management of orthopaedic outpatients by physiotherapists may be useful in reducing public hospital waiting lists. Physiotherapists in Australia are prevented by legislation and funding models from investigating, prescribing, injecting and referring autonomously. This gap in service is particularly noticeable in the management of shoulder pain in early-access physiotherapy services, as patients needing corticosteroid injection face delays or transfer to other services for this procedure. This trial will investigate the clinical (decision making and outcomes) and economic feasibility of a physiotherapist prescribing and delivering corticosteroid and local anaesthetic injections for shoulder pain in an Australian public hospital setting. Methods/Design A double-blinded (patient and assessor) non-inferiority randomised controlled trial will compare an orthopaedic surgeon and a physiotherapist prescribing and delivering corticosteroid injections to the shoulder. Agreement in decision making between the two clinicians will be investigated, and economic information will be obtained for estimating disease burden and an economic evaluation. The surgeon and the physiotherapist will independently assess patients, and 64 eligible participants will be randomised to receive subacromial injection of corticosteroid and local anaesthetic from either the surgeon or the physiotherapist. Post-injection, all participants will receive physiotherapy. The primary outcome measure will be the Shoulder Pain and Disability Index measured at baseline, and at 6 and 12?weeks post-injection. Analysis will be conducted on an intention-to-treat basis and compared to a per-protocol analysis. A cost-utility analysis will be undertaken from the perspective of the health funder. Discussion Findings will assist policy makers and services in improving access for orthopaedic patients. Trial registration Australia and New Zealand Clinical Trials Registry: 12612000532808 First registered: 21 May 2012. First participant randomized: 16 January 2013.